Codiak BioSciences, Inc. Common Stock
CDAK
CDAK was delisted on the 4th of April, 2023.
56 hedge funds and large institutions have $224M invested in Codiak BioSciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
31% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 13
8% more funds holding
Funds holding: 52 → 56 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less capital invested
Capital invested by funds: $260M → $224M (-$36.1M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $296K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.14M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.88M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$771K |
| 4 |
BlackRock
New York
|
+$752K |
| 5 |
State Street
Boston,
Massachusetts
|
+$558K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$6.15M |
| 2 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$4M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$3.16M |
| 4 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$237K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$215K |
CDAK Hedge Fund Activity: Q3 2021 in Review
56 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Codiak BioSciences, Inc. Common Stock (CDAK) for Q3 2021, worth a combined $224M — down 14% from $260M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CDAK positions and 3 closed out — a net gain of 4 holders — while 17 added to existing stakes and 13 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $2.14M. The largest seller was Franklin Resources, cutting an estimated $6.15M.
- 56 institutional investors held Codiak BioSciences, Inc. Common Stock (CDAK) as of Q3 2021, up from 52 in Q2 2021.
- Funds reported $224M of Codiak BioSciences, Inc. Common Stock stock for Q3 2021, down 14% quarter-over-quarter.
- 7 funds opened new Codiak BioSciences, Inc. Common Stock positions in Q3 2021 and 3 closed out, a net change of +4 holders.
- The largest Codiak BioSciences, Inc. Common Stock buyer in Q3 2021 was Ikarian Capital, an estimated $2.14M added.
- The largest Codiak BioSciences, Inc. Common Stock seller in Q3 2021 was Franklin Resources, an estimated $6.15M sold.
Based on aggregated 13F filings for Q3 2021.